Introduction: The epidemiology of both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among drug users (DUs) is little known in West Africa. The study aimed to assess the prevalence of hepatitis B and C viruses among drug users in Burkina Faso. Methodology: This was a cross-sectional biological and behavioral survey conducted between June and August 2022, among drug users in Ouagadougou and Bobo Dioulasso, the two main cities of Burkina Faso. A respondent-driven sampling (RDS) was used to recruit drug users. Hepatitis B surface antigen was determined using lateral flow rapid test kits and antibodies to hepatitis C virus in serum determined using an Enzyme-Linked Immunosorbent Assay. Data were entered and analyzed using Stata 17 software. Weighted binary logistic regression was used to identify the associated factors of hepatitis B and C infections and a p-value < 0.05 was considered statistically significant. Results: A total of 323 drug users were recruited with 97.5% males. The mean age was 32.7 years old. The inhaled or smoked mode was the most used by drug users. The adjusted hepatitis B and hepatitis C prevalence among study participants were 11.1% and 2.3% respectively. The marital status (p = 0.001), and the nationality (p = 0.011) were significantly associated with hepatitis B infection. The type of drug used was not significantly associated with hepatitis B infection or hepatitis C infection. Conclusion: The prevalence of HBsAg and anti-HCV antibodies among DUs are comparable to those reported in the general population in Burkina Faso. This result suggests that the main routes of contamination by HBV and HCV among DUs are similar to those in the population, and could be explained by the low use of the injectable route by DUs in Burkina Faso.
References
[1]
Hutin, Y.J., Bulterys, M. and Hirnschall, G.O. (2018) How Far Are We from Viral Hepatitis Elimination Service Coverage Targets? Journal of the International AIDS Society, 21, e25050. https://doi.org/10.1002/jia2.25050
[2]
Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G. and Ott, J.J. (2015) Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published between 1965 and 2013. The Lancet, 386, 1546-1555. https://doi.org/10.1016/S0140-6736(15)61412-X
[3]
Tsegay, B., Gebrecherkos, T., Kahsay, A.G. and Abdulkader, M. (2023) Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections among Prisoners in Tigrai, Northern Ethiopia. IDR, 16, 3743-3750. https://doi.org/10.2147/IDR.S410017
[4]
Meda, N., Tuaillon, E., Kania, D., Tiendrebeogo, A., Pisoni, A., Zida, S., et al. (2018) Hepatitis B and C Virus Seroprevalence, Burkina Faso: A Cross-Sectional Study. Bulletin of the World Health Organization, 96, 750-759. https://doi.org/10.2471/BLT.18.208603
[5]
Villa, E., Fattovich, G., Mauro, A. and Pasino, M. (2011) Natural History of Chronic HBV Infection: Special Emphasis on the Prognostic Implications of the Inactive Carrier State versus Chronic Hepatitis. Digestive and Liver Disease, 43, S8-S14. https://doi.org/10.1016/S1590-8658(10)60686-X
[6]
Rao, V.B., Johari, N., du Cros, P., Messina, J., Ford, N. and Cooke, G.S. (2015) Hepatitis C Seroprevalence and HIV Co-Infection in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. The Lancet Infectious Diseases, 15, 819-824. https://doi.org/10.1016/S1473-3099(15)00006-7
[7]
Malta, M., Cavalcanti, S., Gliksman, L., Adlaf, E., Hacker, M., Bertoni, N., et al. (2011) Behavior and Major Barriers Faced by Non-Injectable Drug Users with HBV/HCV Seeking Treatment for Hepatitis and Drug Addiction in Rio de Janeiro, Brazil. Ciência & Saúde Coletiva, 16, 4777-4786. https://doi.org/10.1590/S1413-81232011001300026
[8]
Cox, A.L., El-Sayed, M.H., Kao, J.H., Lazarus, J.V., Lemoine, M., Lok, A.S., et al. (2020) Progress towards Elimination Goals for Viral Hepatitis. Nature Reviews Gastroenterology & Hepatology, 17, 533-542. https://doi.org/10.1038/s41575-020-0332-6
[9]
Taherkhani, R. and Farshadpour, F. (2017) Global Elimination of Hepatitis C Virus Infection: Progresses and the Remaining Challenges. World Journal of Hepatology, 9, 1239-1252. https://doi.org/10.4254/wjh.v9.i33.1239
[10]
Kassa, Y., Million, Y., Biset, S. and Moges, F. (2021) Hepatitis B and Hepatitis C Viral Infections and Associated Factors among Prisoners in Northeast Ethiopia. Journal of Blood Medicine, 12, 561-570. https://doi.org/10.2147/JBM.S314556
[11]
Degenhardt, L., Whiteford, H.A., Ferrari, A.J., Baxter, A.J., Charlson, F.J., Hall, W.D., et al. (2013) Global Burden of Disease Attributable to Illicit Drug Use and Dependence: Findings from the Global Burden of Disease Study 2010. The Lancet, 382, 1564-1574. https://doi.org/10.1016/S0140-6736(13)61530-5
[12]
Aghaei, A.M., Gholami, J., Sangchooli, A., Rostam-Abadi, Y., Olamazadeh, S., Ardeshir, M., et al. (2023) Prevalence of Injecting Drug Use and HIV, Hepatitis B, and Hepatitis C in People Who Inject Drugs in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis. The Lancet Global Health, 11, e1225-e1237. https://doi.org/10.1016/S2214-109X(23)00267-X
[13]
Leprêtre, A., Ba, I., Lacombe, K., Maynart, M., Toufik, A., Ndiaye, O., et al. (2015) Prevalence and Behavioral Risks for HIV and HCV Infections in a Population of Drug Users of Dakar, Senegal: The ANRS 12243 UDSEN Study. Journal of the International AIDS Society, 18, 19888. https://doi.org/10.7448/IAS.18.1.19888
[14]
Guure, C., Obiri-Yeboah Laryea, S.M., Dery, S., Baptista da Silva, C., Asamoah-Adu, C., Ayisi-Addo, S., et al. (2022) Behavioural Risk for HIV, Hepatitis B, and Hepatitis C Infections among a Population of Drug Users and Injectors across Four Regions in Ghana. Interdisciplinary Perspectives on Infectious Diseases, 2022, Article ID: 2544481. https://doi.org/10.1155/2022/2544481
[15]
Ekouevi, D.K., Coffie, P.A., Salou, M., Kariyiare, B.G., Dagnra, A.C., Tchounga, B., et al. (2013) Séroprévalence du VIH chez les usagers de drogues au Togo. Santé Publique, 25, 491-498. https://doi.org/10.3917/spub.134.0491
[16]
Hwang, L.Y., Ross, M.W., Zack, C., Bull, L., Rickman, K. and Holleman, M. (2000) Prevalence of Sexually Transmitted Infections and Associated Risk Factors among Populations of Drug Abusers. Clinical Infectious Diseases, 31, 920-926. https://doi.org/10.1086/318131
[17]
Scheibe, A., Young, K., Versfeld, A., Spearman, C.W., Sonderup, M.W., Prabdial-Sing, N., et al. (2020) Hepatitis B, Hepatitis C and HIV Prevalence and Related Sexual and Substance Use Risk Practices among Key Populations Who Access HIV Prevention, Treatment and Related Services in South Africa: Findings from a Seven-City Cross-Sectional Survey (2017). BMC Infectious Diseases, 20, Article No. 655. https://doi.org/10.1186/s12879-020-05359-y
[18]
Scheibe, A., Young, K., Moses, L., Basson, R.L., Versfeld, A., Spearman, C.W., et al. (2019) Understanding Hepatitis B, Hepatitis C and HIV among People Who Inject Drugs in South Africa: Findings from a Three-City Cross-Sectional Survey. Harm Reduction Journal, 16, Article No. 28. https://doi.org/10.1186/s12954-019-0298-2
[19]
Zida, S., Cissé, K., Ky-Zerbo, O., Kambiré, D., Soubeiga, S., Tiendrebéogo, S., et al. (2023) Sero-Epidemiology of HIV and Syphilis and Associated Factors among Drug Users in Burkina Faso, West Africa. International Journal of Virology, 19, 13-20. https://doi.org/10.3923/ijv.2023.13.20
[20]
Sawadogo, A., Kyelem, C.G., Yaméogo, T.M., Barro, L., Kamboulé, B.E. and Dahourou, H. (2015) Statut du portage du virus de l’hépatite B (VHB) au sein du personnel de santé du CHU Sourô Sanou de Bobo-Dioulasso, Burkina Faso. Journal Africain d’Hépato-Gastroentérologie, 1, 30-34. https://doi.org/10.1007/s12157-014-0582-4
[21]
Lingani, M., Akita, T., Ouoba, S., Sanou, A.M., Sugiyama, A., Tarnagda, Z., et al. (2018) High Prevalence of Hepatitis B Infections in Burkina Faso (1996-2017): A Systematic Review with Meta-Analysis of Epidemiological Studies. BMC Public Health, 18, Article No. 551. https://doi.org/10.1186/s12889-018-5432-7
[22]
Keane, E., Funk, A.L. and Shimakawa, Y. (2016) Systematic Review with Meta-Analysis: The Risk of Mother-to-Child Transmission of Hepatitis B Virus Infection in Sub-Saharan Africa. Alimentary Pharmacology & Therapeutics, 44, 1005-1017. https://doi.org/10.1111/apt.13795
[23]
Ouedraogo, H.G., Kouanda, S., Grosso, A., Compaoré, R., Camara, M., Dabire, C., et al. (2018) Hepatitis B, C, and D Virus and Human T-Cell Leukemia Virus Types 1 and 2 Infections and Correlates among Men Who Have Sex with Men in Ouagadougou, Burkina Faso. Virology Journal, 15, Article No. 194. https://doi.org/10.1186/s12985-018-1110-8
[24]
Ouedraogo, H.G., Kouanda, S., Goodman, S., Lanou, H.B., Ky-Zerbo, O., Samadoulougou, B.C., et al. (2019) Hepatitis B, C and Delta Viruses’ Infections and Correlate Factors among Female Sex Workers in Burkina Faso, West-Africa. The Open Virology Journal, 13, 9-17. https://doi.org/10.2174/1874357901913010009 https://benthamopen.com/ABSTRACT/TOVJ-13-9
[25]
Tun, W., Vu, L., Adebajo, S.B., Abiodun, L., Sheehy, M., Karlyn, A., et al. (2013) Population-Based Prevalence of Hepatitis B and C Virus, HIV, Syphilis, Gonorrhea and Chlamydia in Male Injection Drug Users in Lagos, Nigeria. International Journal of STD & AIDS, 24, 619-625. https://doi.org/10.1177/0956462413477553
[26]
Wu, J., Huang, J., Xu, D., Lu, C., Deng, X. and Zhou, X. (2010) Infection Status and Risk Factors of HIV, HBV, HCV, and Syphilis among Drug Users in Guangdong, China—A Cross-Sectional Study. BMC Public Health, 10, Article No. 657. https://doi.org/10.1186/1471-2458-10-657
[27]
Tao, I., Compaoré, T.R., Diarra, B., Djigma, F., Zohoncon, T.M., Assih, M., et al. (2014) Seroepidemiology of Hepatitis B and C Viruses in the General Population of Burkina Faso. Hepatitis Research and Treatment, 2014, Article ID: 781843. https://doi.org/10.1155/2014/781843
[28]
Demissie, M., Johnston, L.G., Muleta, M., Desyebelew, D., Belete, W., G/Egxiabehre, A., et al. (2018) Prevalence of HIV and Other Infections and Injection Behaviours among People Who Inject Drugs in Addis Ababa, Ethiopia. African Journal of AIDS Research, 17, 259-264. https://doi.org/10.2989/16085906.2018.1511604
[29]
Kpelly, E., Schauder, S., Bohm, M.K., Sounga, D. and Moukouta, C. (2022) Profiles and Health Risks (STIs, HCV, HIV) of Injecting Drug Users. Revue d’Épidémiologie et de Santé Publique, 70, 299-304. https://doi.org/10.1016/j.respe.2022.08.007
[30]
Rossi, D., Radulich, G., Muzzio, E., Naveira, J., Sosa-Estani, S., Rey, J., et al. (2008) Multiple Infections and Associated Risk Factors among Non-Injecting Cocaine Users in Argentina. Cadernos de Saúde Pública, 24, 965-974. https://doi.org/10.1590/S0102-311X2008000500003
